Who
John W. Sharkey
VP, Business Development
Company insider
Files Form 4 as: VP, Business Development, GeoVax Labs.
In numbers
- Trades disclosed
- 7
- Buys
- 2
- Sells
- 0
- Bought
- $6,760
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2022
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 10 Apr 2025filed 10 Apr 2025 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $5,9406,000 at $0.99 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,700 at $0.00 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 1 Jul 2022filed 5 Jul 2022 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $8201,000 at $0.82 | filing |
News
No headline names them, or the companies they trade most, lately.